Arkolith/Insider Trading/INDP/Form 4

Meckler Jeffrey A

CEO and Director, DirectorIndaptus Therapeutics, Inc. (INDP) · full profile →Form 4 · filed Sep 8, 2022
Net Buying
Open-Market Buys
$25K
Open-Market Sells
$0
Net Open-Market Flow
$25K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 7, 2022Buy(P)9K$2.57$22K55K
Sep 6, 2022Buy(P)1K$2.44$3K46K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-025319) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML